Sign in
Mei-Neng Wang
ORCID
Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 8
Top Topics
Protein Interaction
Negative Matrix Factorization
Least Squares
Latent Semantic Space
Top Venues
ICIC (3)
BMC Bioinform.
ICIC (2)
IEEE ACM Trans. Comput. Biol. Bioinform.
</>
Publications
</>
Mei-Neng Wang
,
Xue-Jun Xie
,
Zhu-Hong You
,
Leon Wong
,
Li-Ping Li
,
Zhan-Heng Chen
Combining K Nearest Neighbor With Nonnegative Matrix Factorization for Predicting Circrna-Disease Associations.
IEEE ACM Trans. Comput. Biol. Bioinform.
20 (5) (2023)
Mei-Neng Wang
,
Zhu-Hong You
,
Lei Wang
,
Li-Ping Li
,
Kai Zheng
LDGRNMF: LncRNA-disease associations prediction based on graph regularized non-negative matrix factorization.
Neurocomputing
424 (2021)
Mei-Neng Wang
,
Xue-Jun Xie
,
Zhuhong You
,
Leon Wong
,
Liping Li
,
Zhan-Heng Chen
Weighted Nonnegative Matrix Factorization Based on Multi-source Fusion Information for Predicting CircRNA-Disease Associations.
ICIC (3)
(2021)
Zhen-Hao Guo
,
Zhan-Heng Chen
,
Zhu-Hong You
,
Yan-Bin Wang
,
Hai-Cheng Yi
,
Mei-Neng Wang
A learning-based method to predict LncRNA-disease associations by combining CNN and ELM.
BMC Bioinform.
(5) (2021)
Xin Yan
,
Zhu-Hong You
,
Lei Wang
,
Li-Ping Li
,
Kai Zheng
,
Mei-Neng Wang
DTIFS: A Novel Computational Approach for Predicting Drug-Target Interactions from Drug Structure and Protein Sequence.
ICIC (2)
(2020)
Hai-Cheng Yi
,
Zhu-Hong You
,
Mei-Neng Wang
,
Zhen-Hao Guo
,
Yan-Bin Wang
,
Ji-Ren Zhou
RPI-SE: a stacking ensemble learning framework for ncRNA-protein interactions prediction using sequence information.
BMC Bioinform.
21 (1) (2020)
Mei-Neng Wang
,
Zhu-Hong You
,
Li-Ping Li
,
Zhan-Heng Chen
,
Xue-Jun Xie
WGMFDDA: A Novel Weighted-Based Graph Regularized Matrix Factorization for Predicting Drug-Disease Associations.
ICIC (3)
(2020)
Mei-Neng Wang
,
Zhu-Hong You
,
Li-Ping Li
,
Leon Wong
,
Zhan-Heng Chen
,
Chengzhi Gan
GNMFLMI: Graph Regularized Nonnegative Matrix Factorization for Predicting LncRNA-MiRNA Interactions.
IEEE Access
8 (2020)